Supplementary figure 1Supplementary Table S1. Thiol group quantification assaySupplementary Table S2. Kinetic characteristics of DTX release from formulations of CS/SH-HA nanoparticlesSupplementary Table S3. An acute oral toxicity investigation for SH-HA nanoparticles with clinical outcomesSupplementary Table S4. Stability study of the thiolated NP formulation at different storage conditions for three months</p